Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Comparative Effects of Autogenic Inhibition and Reciprocal Inhibition Technique on Pain, Functional Disability and Gait in Sacroiliac Joint Dysfuction.

14 mai 2026 mis à jour par: Foundation University Islamabad
Sacro-iliac joint act as the shock absorber of the body. It is responsible for transferring vertical load of the whole body to lower limb hence contributing to stability of pelvic girdle. However, SI joint dysfunction is one of the most common causes of low back pain among the patients suffering from non-radicular low back pain. There can be a mechanical source which is due to muscle insufficiency or instability or a non-mechanical source which is osteoarthritis, infection or any trauma. It is thought to affect females more commonly with prevalence of about 46.71% in females and with the prevalence of about 15 to 30% in general. This poses great threat to bio mechanics of the body which can significantly lead to disability that can affect mobility, daily activities and quality of life of the individual. According to a study the pain caused by SIJD caused activity limitation and participation restriction of about 25% of the individuals. Hence making it difficult for them to continue their jobs. increased pain leads to worsening of the ability to perform ADLs which ultimately effects the quality of life. Altered biomechanics also leads to alteration in spatio temporal gait parameters.This study aims to compare the effects of autogenic inhibition technique and reciprocal inhibition technique in addition with conventional therapy in reliving low back pain, improving functional disability and alteration in spatio-temporal gait parameters in patients with sacroiliac joint dysfunction. Patients with SIJD will be recruited and will be randomly divided into two groups 20 in each group. Group 1 will receive autogenic inhibition technique of iliopsas, hamstrings, erector spinae and piriformis muscles along with standard core stabilization exercises and group 2 will receive reciprocal inhibition technique on iliopsas, hamstrings, erector spinae and piriformis muscles along with standard core stabilization exercises. The treatment will be continued for 3 weeks with 4 sessions of 25 minutes per week.

Aperçu de l'étude

Statut

Recrutement

Les conditions

Intervention / Traitement

Description détaillée

Participants will be divided into two groups and a total of 12 sessions will be given for 3 weeks with a frequency of 4 sessions per week and a duration of 25 minutes. Group 1 will be given autogenic inhibition technique of iliopsoas, Piriformis, hamstrings and erector spinae along with core stability exercises and conentional therapy. Group 2 will be given reciprocal inhibition techniques of iliopsoas, Piriformis, hamstrings and erector spinae along with conventional treatment and core stability exercises.

Group 1 Group 2 WEEK 1 4 SESSEIONS/ WEEK

  • TENS + hot pack ⇢10 mins
  • drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold
  • Bridiging ⇢5 reps ⇢no hold
  • PIR of illiopsoas ⇢5 reps ⇢10 sec hold
  • PIR of PIRiformis ⇢5 reps ⇢10 sec hold
  • PIR of hamstrings ⇢5 reps ⇢10 sec hold
  • PIR of erector spinae ⇢5 reps ⇢10 sec hold • TENS + hot pack ⇢10 mins
  • drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold
  • Bridiging ⇢5 reps ⇢no hold
  • RI-MET of illiopsoas ⇢5 reps ⇢10 sec hold
  • RI-MET of PIRiformis ⇢5 reps ⇢10 sec hold
  • RI-MET of hamstrings ⇢5 reps ⇢10 sec hold
  • RI-MET of erector spinae ⇢5 reps ⇢10 sec hold Group 1 Group 2 WEEK 2 4 SESSEIONS/ WEEK
  • TENS + hot pack ⇢10 mins
  • drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold
  • Bridiging ⇢5reps ⇢3 sec hold
  • Clam shell exercises ⇢6 reps
  • PIR of illiopsoas ⇢7 reps ⇢10 sec hold
  • PIR of PIRiformis ⇢7 reps ⇢10 sec hold
  • PIR of hamstrings ⇢ 7 reps ⇢10 sec hold
  • PIR of erector spinae ⇢7 reps ⇢10 sec hold • TENS + hot pack ⇢10 mins
  • drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold
  • Bridiging ⇢5reps ⇢3 sec hold
  • Clam shell exercises ⇢6 reps
  • RI-MET of illiopsoas ⇢7 reps ⇢10 sec hold
  • RI-MET of PIRiformis ⇢7 reps ⇢10 sec hold
  • RI-MET of hamstrings ⇢ 7 reps ⇢10 sec hold
  • RI-MET of erector spinae ⇢7 reps ⇢10 sec hold

Group 1 Group 2 WEEK 3 4 SESSEIONS/ WEEK

  • TENS + hot pack ⇢10 mins
  • drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold
  • Supine Bridiging ⇢10 reps ⇢ 6 sec hold
  • Clam shell exercises ⇢10 reps ⇢6 sec hold
  • PIR of illiopsoas ⇢10 reps ⇢10 sec hold
  • PIR of PIRiformis ⇢10 reps ⇢10 sec hold
  • PIR of hamstrings ⇢10 reps ⇢ 10 sec hold
  • PIR of erector spinae ⇢ 10 reps ⇢10 sec hold
  • TENS + hot pack ⇢10 mins
  • drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold
  • Supine Bridiging ⇢10 reps ⇢ 6 sec hold
  • Clam shell exercises ⇢10 reps ⇢6 sec hold
  • RI-MET of illiopsoas ⇢10 reps ⇢10 sec hold
  • RI-MET of PIRiformis ⇢10 reps ⇢10 sec hold
  • RI-MET of hamstrings ⇢10 reps ⇢ 10 sec hold
  • RI-MET of erector spinae ⇢ 10 reps ⇢10 sec hold

Type d'étude

Interventionnel

Inscription (Estimé)

40

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Sauvegarde des contacts de l'étude

  • Nom: Marwa Asim, MS-OMPT
  • Numéro de téléphone: 03335339457
  • E-mail: marwa@fui.edu.pk

Lieux d'étude

  • Pakistan
    • Punjab Province
      • Islamabad, Punjab Province, Pakistan, 44000
        • Recrutement
        • Foundation University College of Physical Therapy
        • Contact:
        • Contact:
          • Marwa Asim, MS-OMPT
          • Numéro de téléphone: 03335339457
          • E-mail: marwa@fui.edu.pk

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Patients having low back pain greater than 4 weeks
  • Patients with positive gaenslen's test, thigh thurst test, standing flexion test, sacral compression and distraction test.
  • Patients not having any other condition that can affect gait
  • 25-45 years
  • Both males and females

Exclusion Criteria:

  • Patients having nonspecific low back
  • Patients with lumbosacral fusion
  • Patients with any neurological condition
  • Patients with history of trauma of spine
  • Patients with any other lumbar spine condition (lumbar radiculopathy, spinal stenosis, spondylolisthesis, inflammatory arthritis)
  • Patients with any hip joint pathology
  • Patients using any assistive device

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Autogenic Inhibition Technique

During week 1, group 1 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold PIR of illiopsoas ⇢5 reps ⇢10 sec hold PIR of PIRiformis ⇢5 reps ⇢10 sec hold PIR of hamstrings ⇢5 reps ⇢10 sec hold PIR of erector spinae ⇢5 reps ⇢10 sec hold

During week 2, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps PIR of illiopsoas ⇢7 reps ⇢10 sec hold PIR of PIRiformis ⇢7 reps ⇢10 sec hold PIR of hamstrings ⇢ 7 reps ⇢10 sec hold PIR of erector spinae ⇢7 reps ⇢10 sec hold

During week 3, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging ⇢10 reps ⇢ 6 sec hold Clam shell exercises ⇢10 reps ⇢6 sec hold PIR of illiopsoas ⇢10 reps ⇢10 sec hold PIR of PIRiformis ⇢10 reps ⇢10 sec hold PIR of hamstrings ⇢10 reps ⇢ 10 sec
Procédure: Autogenic Inhibition
During week 1, group 1 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position Bridiging PIR of illiopsoas,Piriformis, hamstrings,erector spinae During week 2, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position Bridiging Clam shell exercises PIR of illiopsoas, PIRiformis, hamstrings, erector spinae During week 3, group 1 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position Supine Bridiging, Clam shell exercises, PIR of illiopsoas PIR of Piriformis, hamstrings and erector spinae
Expérimental: Reciprocal Inhibition Technique

During week 1, group 2 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold RI-MET of illiopsoas ⇢5 reps ⇢10 sec hold RI-MET of PIRiformis ⇢5 reps ⇢10 sec hold RI-MET of hamstrings ⇢5 reps ⇢10 sec hold RI-MET of erector spinae ⇢5 reps ⇢10 sec hold

During week 2, group 2 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps RI-MET of illiopsoas ⇢7 reps ⇢10 sec hold RI-MET of PIRiformis ⇢7 reps ⇢10 sec hold RI-MET of hamstrings ⇢ 7 reps ⇢10 sec hold RI-MET of erector spinae ⇢7 reps ⇢10 sec hold

During week 3, group 2 will receive TENS + hot pack ⇢10 mins drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging ⇢10 reps ⇢ 6 sec hold Clam shell exercises ⇢10 reps ⇢6 sec hold RI-MET of illiopsoas ⇢10 reps ⇢10 sec hold RI-MET of PIRiformis ⇢10 reps ⇢10 sec hold RI-MET o
Procédure: Reciprocal Inhibition
During week 1, group 2 will receive TENS + hot pack ⇢10 mins Drawing in maneuver in quadruped position ⇢7 reps ⇢3 sec hold Bridiging ⇢5 reps ⇢no hold RI-MET of illiopsoas, PIRiformis, hamstrings, erector spinae ⇢5 reps ⇢10 sec hold During week 2, group 2 will receive TENS + hot pack ⇢10 mins Drawing in manuver in quadruped position ⇢7 reps ⇢6 sec hold Bridiging ⇢5reps ⇢3 sec hold Clam shell exercises ⇢6 reps RI-MET of illiopsoas, PIRiformis, hamstrings, erector spinae ⇢7 reps ⇢10 sec hold During week 3, group 2 will receive TENS + hot pack ⇢10 mins drawing in manuver in quadruped position ⇢8 reps ⇢8 sec hold Supine Bridiging, Clam shell exercises ⇢10 reps ⇢6 sec hold RI-MET of illiopsoas, Piriformis, erector spinae ⇢10 reps ⇢10 sec hold

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Functional disability
Délai: before treatment after after 3 weeks
It will be measured by using Denver SI joint disability questionnaire which 10 questions questionnaire consisting of scoring range from 0-5 in each item answered. 0 means no disability and 5 means maximum disability. And total score is calculated in the form of percentage. Higher the percentage greater is the disability.
before treatment after after 3 weeks
Pain intensity
Délai: before treatment and after 3 weeks
Pain will be measured by NPRS. A line of 10 centimeters containing numbers from 0 to 10 marked. The starting point of the scale indicates 0 or no pain whereas the ending point marks the pain as 10 which means the pain is as worse as it could be.
before treatment and after 3 weeks
Gait Speed
Délai: Assessed at baseline (before intervention) and after 3 weeks of intervention.

Gait speed will be measured by calculating the distance covered in meters divided by the time taken in seconds during walking assessment.

Formula: Gait Speed (m/s) = Distance (m) × Time (s)
Assessed at baseline (before intervention) and after 3 weeks of intervention.
Cadance
Délai: Assessed at baseline (before intervention) and after 3 weeks of intervention.

Cadence will be measured as the number of steps taken per minute during walking assessment.

Formula: Cadence (steps/min) = Steps Counted × 60 / Time (s)
Assessed at baseline (before intervention) and after 3 weeks of intervention.
Cycle time
Délai: Assessed at baseline (before intervention) and after 3 weeks of intervention.

Cycle time will be calculated as the time required to complete one gait cycle during walking assessment.

Formula: Cycle Time (s) = Time (s) × 2 / Steps Counted
Assessed at baseline (before intervention) and after 3 weeks of intervention.
Stride Length
Délai: Assessed at baseline (before intervention) and after 3 weeks of intervention.

Stride length will be determined by multiplying gait speed with cycle time during walking assessment.

Formula: Stride Length (m) = Speed (m/s) × Cycle Time (s)
Assessed at baseline (before intervention) and after 3 weeks of intervention.
Step Length
Délai: Assessed at baseline (before intervention) and after 3 weeks of intervention.

Step length will be calculated as half of the stride length obtained during gait assessment.

Formula: Step Length (m) = Stride Length / 2
Assessed at baseline (before intervention) and after 3 weeks of intervention.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Foundation University Islamabad

Les enquêteurs

  • Chercheur principal: Fajar Sajjad, DPT, Foundation University Islamabad

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

15 mai 2026

Achèvement primaire (Estimé)

1 juillet 2026

Achèvement de l'étude (Estimé)

15 juillet 2026

Dates d'inscription aux études

Première soumission

14 mai 2026

Première soumission répondant aux critères de contrôle qualité

14 mai 2026

Première publication (Réel)

20 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

20 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

14 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • FUI/FUCP/CTR/10.26/FajarSajad

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner